EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Coronary Slow Flow and No‐Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging‐Guided Prediction, Prevention, and Management

Bharat Khialani, Eran Sim, George Touma, Sarah Fairley iD, Cuneyt Ada, Bernard Wong iD

Catheterization and Cardiovascular Interventions · 2026-03 · 107 (4) · 1198-1205

DOI: 10.1002/ccd.70468 ↗

At a glance

Übersichtsarbeit in Catheterization and Cardiovascular Interventions, published online on 2026-01-07. Written by Bharat Khialani and 5 co-authors. Institution: Department of Cardiovascular Medicine, Tan Tock Seng Hospital, National Healthcare Group, Jln Tan Tock Seng, Singapore. Major MEDLINE topics: No-Reflow Phenomenon, Percutaneous Coronary Intervention, Coronary Circulation, Coronary Angiography. Cited 4 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Coronary slow flow (SF) and no‐reflow (NR) are clinically significant complications of percutaneous coronary intervention (PCI), particularly in ST‐segment elevation myocardial infarction (STEMI) and saphenous vein graft (SVG) interventions. Angiographically defined as impaired myocardial perfusion despite restored epicardial patency, SF/NR results from microvascular dysfunction driven by distal embolization, ischemia–reperfusion injury, microvascular spasm, capillary plugging and emerging molecular mechanisms such as endothelial glycocalyx degradation and microRNA‐mediated inflammatory pathways. These processes contribute to larger infarct size, maladaptive remodeling, and increased mortality. Advanced intracoronary imaging enables lesion‐level risk stratification by identifying features such as lipid‐rich cores, thin‐cap fibroatheromas, positive remodeling, and thrombus. Image‐guided strategies, incorporating deferred stenting, selective aspiration, and tailored lesion preparation, can mitigate distal embolization. Risk stratification models (e.g., PAMI score) and recognition of sex‐ and race‐based disparities further refine procedural planning. Cost, accessibility, and emerging AI‐driven automated plaque characterization tools are important considerations for wider implementation. Preventive measures emphasize systemic optimization, adequate anticoagulation, high‐intensity statin pretreatment informed by precision dosing, dual antiplatelet therapy, and refined device techniques in thrombus‐rich or calcified lesions. Management requires early recognition, systematic exclusion of mimics such as dissection or epicardial spasm, maintenance of anticoagulation, and rapid stepwise administration of intracoronary microvasculature dilators. Device‐based delivery methods offer practical advantages but carry specific risks, including device entrapment or vessel trauma. Adjunctive therapies such as supersaturated oxygen may be considered in refractory cases. A structured, imaging‐informed algorithm integrating preventive strategies, pharmacologic escalation, and device‐assisted therapy may reduce SF/NR incidence and improve procedural and long‐term outcomes. Future research should validate imaging‐guided preventive strategies, standardized rescue protocols, and the role of AI‐driven risk assessment in diverse patient populations.

Subjects

MeSH terms (MEDLINE)

No-Reflow PhenomenonPercutaneous Coronary InterventionCoronary CirculationCoronary AngiographyCoronary Artery DiseaseST Elevation Myocardial InfarctionHumansPredictive Value of TestsRisk FactorsTreatment OutcomeRisk AssessmentBlood Flow Velocity

Authors and institutions

  • Department of Cardiovascular Medicine, Tan Tock Seng Hospital, National Healthcare Group, Jln Tan Tock Seng, Singapore.
  • Hurstville Private Hospital, Sydney, New South Wales, Australia.
  • Wellington Cardiology Department, Wellington Hospital, Wellington, New Zealand.
  • Department of Cardiology, Macquarie University Hospital, Sydney, New South Wales, Australia.
  • Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Auckland, New Zealand.
  • Department of Cardiology, North Shore Hospital, Auckland, New Zealand.

ORCID profiles: Sarah Fairley, Bernard Wong

Cite

APA

Khialani, B., Sim, E., Touma, G., Fairley, S., Ada, C., & Wong, B. (2026). Coronary Slow Flow and No‐Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging‐Guided Prediction, Prevention, and Management. Catheterization and Cardiovascular Interventions, 107(4), 1198-1205. https://doi.org/10.1002/ccd.70468

Vancouver

Khialani B, Sim E, Touma G, Fairley S, Ada C, Wong B. Coronary Slow Flow and No‐Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging‐Guided Prediction, Prevention, and Management. Catheterization and Cardiovascular Interventions. 2026;107(4):1198-1205. doi:10.1002/ccd.70468

BibTeX
@article{Khialani2026,
  author = {Khialani, Bharat and Sim, Eran and Touma, George and Fairley, Sarah and Ada, Cuneyt and Wong, Bernard},
  title = {Coronary Slow Flow and No‐Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging‐Guided Prediction, Prevention, and Management},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {4},
  pages = {1198--1205},
  doi = {10.1002/ccd.70468}
}
Start for free →